Clinically, FXR is significantly overexpressed in Barrett’s esophagus, and the overexpression of FXR in esophageal adenocarcinoma was associated with a higher tumor grade, greater tumor size, and lymph node metastasis [109,111]. The gene discussed is NR1H4; the disease is esophageal adenocarcinoma.